SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015147
Filing Date
2021-11-09
Accepted
2021-11-09 06:36:03
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20210930x10q.htm   iXBRL 10-Q 2866149
2 EX-31.1 imrx-20210930xex31d1.htm EX-31.1 14687
3 EX-31.2 imrx-20210930xex31d2.htm EX-31.2 15954
4 EX-32.1 imrx-20210930xex32d1.htm EX-32.1 9360
5 EX-32.2 imrx-20210930xex32d2.htm EX-32.2 9982
  Complete submission text file 0001558370-21-015147.txt   8002770

Data Files

Seq Description Document Type Size
6 EX-101.SCH imrx-20210930.xsd EX-101.SCH 42232
7 EX-101.CAL imrx-20210930_cal.xml EX-101.CAL 48643
8 EX-101.DEF imrx-20210930_def.xml EX-101.DEF 208482
9 EX-101.LAB imrx-20210930_lab.xml EX-101.LAB 394487
10 EX-101.PRE imrx-20210930_pre.xml EX-101.PRE 339786
11 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20210930x10q_htm.xml XML 1087935
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 211389784
SIC: 2834 Pharmaceutical Preparations